LYSOLECITHN has been widely studied as a surface-active haemolytic agent (Robinson, 1961) and has been implicated in immune haemolysis (Fischer, 1964), in hypersensitivity reactions (Middleton and Phillips, 1963, 1964) , and in the delayed stage of the increase of vascular permeability in inflammation (Cotran and Majno, 1964). Fischer (1964) found that the oxygen uptake (Q02) of tumour cells was reduced by small concentrations of "lysolecithin ", while micro and macrophages responded by an increase Of Q02 and phagocytic activity. We felt that this observation should be confirmed, because it could form the basis of a therapeutic method of increasing the radiosensitivity of tumours by raising the oxygen tension (PO2), and from the theoretical aspect might clarify differences between the cell membranes of tumour and of normal cells. Moreover, Fischer's experiments are open to criticism. His cell suspension was stirred by a moving mercury seal and this could have produced cell damage from mercury poisoning. Also he treated his cell suspensions not with lysolecithin, but with complement plus a specific antibody against cell antigen, and assumed, from previous work, that these would liberate lysolecithin at the cell surface. Phillips and Middleton (1965), however, could not demonstrate the production of-lysolecithin in an immune haemolytic system. Fischer used Munder's modification of the Clark oxygen cathode to record changes of P02 in his cell suspension; in the present work we used membrane covered electrodes (Silver, 1963) which have a greater sensitivity and a much faster response-time than the Clark electrode (1-3 sec. for 95% response). 
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Our aims were -(a) to find a reproducible method for comparing the oxygen uptake of treated and control cells; (b) to examine the concentration of lysolecithin that would affect the oxygen uptake of ascites tumour cells; and (c) to test the effect of such a concentration on polymorphonuclear leucocytes, lymphocytes and macrophages.
METHODS

Solutions
All vessels, pipettes, etc. used in preparing cell suspensions were of siliconed glassware or non-wettable plastic. Cell suspensions were diluted with tris-* Gibb Fellow of the British Empire Cancer Campaign for Research. citrate buffered Hanks' balanced salt solution (Hanks, 1948) , pH 6-9 to 7-2, containing heparin, 3 mg.% w/v, and streptomycin 100 I.U./ml. (abbreviated to Hanks ' H soln.) Lysolecithin (Koch-Light Lab. " pure lysolecithin, batch 18994 ", and " pure lysolecithin (ex egg lecithin, crystallized, batch 25436 ") was prepared by grinding with Ringer phosphate pH 7 0-7 3 in a mortar for 5 min. after the method of Dawson, Mann and White (1957) . The slightly opaque, " soapy " suspension (1.5-2.0 mg. lysolecithin/ml.) was used within 2 hours of preparation. In pilot experiments, when lysolecithin was merely shaken with Ringer phosphate, little effect on the oxygen uptake of cells was observed. The lysolecithin in such cases may have formed a surface film.
Technique of measurement of the oxygen tension (PO2) in cell suspensions
The oxygen-cathode (Silver, 1963) was inserted into a siliconed glass cuvette containing a stirrer and 1 0-1 3 ml. of cell suspension, as shown in Fig. 1. (A layer of cell-suspension above the constriction of the cuvette formed a buffer of cells and prevented oxygen leaking from the air through imperfections of electrode/ cuvette fit). Two such cuvettes with electrodes were immersed in a small water bath placed on top of a magnetic stirrer which rotated the stirrer rods (iron wire in siliconed glass) in both cuvettes. The small water bath was kept at constant temperature by a flow of water at 5 ml./sec. from a large thermostatically controlled water bath. Each electrode was connected to a polarizing voltage of 0-6 V. and an amplifier, as described by Cater, Silver and Wilson (1959) .
Calibration.-The electrode gives a small current in N2, but when this is subtracted the p02/current response is linear. N2 currents were determined by passing N2 via a copper tube through a stainless steel cuvette with which the electrode made a gas-tight fit. Water equilibrated with air at 370 C. was used to calibrate the electrodes. The absolute value was only important in calculating absolute oxygen uptake, not in comparing treated and untreated cells. Calibration of electrodes was checked before each experiment.
Experimental procedure.-A known volume of well-mixed cell suspension was added to each cuvette and allowed to reach 370 C. Suspensions were oxygenated either directly or by adding a known volume of oxygenated Hanks' H soln. to the cuvette, with calculation of the new number of cells/ml. The electrodes were then fitted and readings taken at 0 5-3 minute intervals. The zero drift of each amplifier was corrected every 3 minutes. Then lysolecithin soln. was 30 mm. Hg. This effect was not due to agglutination, because no gross agglutination was seen and re-oxygenation restored the post-lysolecithin Vmax.
As already noted, a reduction of normal 02 uptake/total cells/ml./min.
occurred with increasing age of BP8 tumour. This was due to an increasing %/0 of dead cells in the tumours harvested on the 13, 14 and 15th day. It was thought that dead cells might absorb lysolecithin and therefore more lysolecithin would be needed to produce the same degree of inhibition. Because old tumours were avoided data on this point are scanty, but 14 day tumours needed a higher dose of lysolecithin for 50 % inhibition than 11 day tumours, whereas 12-13 day tumours were more sensitive to the action of lysolecithin. 
Polym orphonuclear leucocytes
Polymorphonuclear leucocytes proved difficult to work with, because untreated cells showed a marked tendency to coagulate in vitro, and this sometimes caused an apparent decrease of oxygen uptake with time, as seen in With lysolecithin, the rate of oxygen uptake showed a characteristic progressive decrease (Fig. 6, curve B) : therefore values for % inhibition were read from the gradient of the curve immediately after addition of the drug. A linear relationship between % inhibition and log [dose of lysolecithin/106 cells] was again found (Fig. 7) 
Macrophayes
The oxygen uptake of the normal cells was variable; Q02= 0-14-0-44 with a mean of 0-27 ± 0*028 /tmoles O2/107 viable cells/hr. Oxygen bubbling damaged the cells. After treatment with lysolecithin the rate of oxygen uptake was constant but reduced. Fig. 8 illustrates a typical experiment. The percentage reduction gave a straight line plot against log [dose of lysolecithin/106 total cells/ml], as shown in Fig. 9 . Lysolecithin 4*24 ,tg./106total cells/ml. gave a 50% reduction (log1o 4-24 = 0-628 ± 0.029). Leslie, Fulton and Sinclair (1957) have pointed out, " it would seem more logical to put results on a per cell basis, since discussions are always made on the assumption that one cell type is being compared with another ". In the present experiment it is the activity of the whole cell, not that of the individual enzyme systems, which is being considered, therefore Q02 has been expressed in terms of ,tmoles O2/107 viable cells per hour. The values obtained are shown in Table I , which also records comparable Q02 values reported by other workers using mammalian leucocytes. We found that BP8 cells and, to a lesser extent, rat hepatoma cells had a higher Q02 per cell than the normal cells studied, but when Q02 was expressed as ,tmoles 02/mg. dry wt/hr, as shown in Table II , the lymphocyte because of its small size gave the highest value.
At low PO2'S the rate of oxygen uptake by the cells diminished, showing that oxygen concentration became a limiting factor. The S Vmax values (the apparent Michaelis constant for oxygen or KMi2) were of the order of 1-5 mm. Hg, but as the system was rapidly altering these values must be regarded as qualitative only. (Longmuir used a polarographic method to find the KmO2 of bacteria (1954) and of liver cells Froese (1962) found a KmO2 of 0-18 mm. Hg for Ehrlich ascites cells.) We found that low concentrations of lysolecithin per cell considerably increased the KmO2 values with little decrease in Vmax. This type of effect is seen in competitive inhibition. It may indicate that these amounts of lysolecithin reduce oxygen uptake by damaging the mitochondria or by switching the metabolism from oxidative to glycolytic pathways. Coagulation was excluded as a cause of this effect.
At higher concentrations of lysolecithin per cell, the percentage inhibition of oxygen uptake increased and was found to be proportional to log [dose of lyso- Tumour cells, however, are considerably larger than the leucocytes studied; and since lysolecithin is a surface active agent, its activity must be expected to depend on the surface area of the cell involved. The diameters of 100 cells of each type were therefore measured under the phase contrast microscope in a hanging drop suspension. These data are shown in Table II , and the means and S.E.M. of the 100 areas calculated from the diameters are shown in Table III .
The 50% inhibition dose in ,ug. per square micron of cell surface was calculated, and on this basis the BP8 tumour cell was found to be most sensitive and the lymphocyte least sensitive to the action of lysolecithin.
This type of analysis we believe is justified by the results of those who have studied the effects of lysolecithin on red cells. For instance, Gorter and Hermans (1943) found that haemolysis occurred when enough lysolecithin was present on the surface of the cell to form a complete monolayer. Hughes (1935) gives 108 A2 for the molecular area of lysolecithin; and Klibansky and de Vries (1963) calculated from this figure that 0.1 ,tg./106 cells would be necessary for lysis, and showed that 0 01 /1g./106 cells, measured by direct lipid analysis, caused sphering of erythrocytes. But they also found that only 20% of the lysolecithin in suspension became attached to the cell membrane, and, from the data of several other workers, a figure of 03 /tg./106 cells emerges for haemolysis by the lysolecithin in suspension. (Gorter and Hermans (1943) , Scarinci, Parenti, Cantone and Ravazzoni (1960); Hartree and Mann (1960) , Phillips and Middleton (1965) .) Taking the area of the erythrocyte as 140 #a2 (Wintrobe, 1952) gives a value of 2 15 x 10-9 ,ug. lysolecithin per It2 of cell surface for the haemolysis of erythrocytes. It will be seen that this value is much less than the 7-5 X 10-9 tg./t2 required to produce 50% inhibition of oxygen uptake in BP8 tumour cells (Table llI) .
The effect of lysolecithin on erythrocytes is probably due to the formation of either lysolecithin-cholesterol complexes (Collier, 1952) or lysolecithin complexes with the lecithin of the cell membrane (Klibansky and de Vries, 1963) . Resulting changes in the micellar shape of the discs of lecithin alter the surface activity of the red cell to produce sphering. (Cooper and Lehninger, 1956) , and low concentrations of lysolecithin protect phospholipids from salt precipitation (Saunders, 1957) . Habermann (1954) found that lysolecithin inactivated the enzymic systems of oxidative phosphorylation in liver homogenates, and suggested that phospholipids played a role between respiration and phosphorylation. Witter, Morrison and Shepardson (1957) found that lysolecithin acted on the binding structures of the enzyme complex rather than on the individual enzymes: inhibition of oxidative phosphorylation would be expected if spatial disarrangement of the enzymes on the mitochondrial cristae occurred. They showed that lysolecithin uncoupled oxidative phosphorylation, decreased the oxidation of substrates and decreased the stability of mitochondria. They postulated that lysolecithin in low concentration played a part in the control of normal oxidative phosphorylation. Nygaard, Dianzani and Bahr (1954) observed disintegration of mitochondria and inactivation of succinoxidase systems. Seven minutes incubation was sufficient: 10 mg./ml. caused complete destruction of the suspension used, while 041 mg./ml. caused less than 10% destruction. Witter and Cottone (1956) observed swelling of isolated mitochondria with lysolecithin. Finally Hartree and Mann (1960) found that lysolecithin caused stimulation of oxygen consumption by ram spermatozoa at concentration less than 1 mm, but inhibition at concentrations greater than this.
In terms of the whole cell, therefore, it may be suggested that lysolecithin has two actions. The first is to increase the permeability of the membrane. This would allow entry of lysolecithin into the cell in sufficient concentrations to disorganize mitochondria and inhibit oxidative phosphorylation. If this were so, it would be suspected that there would be a minimum of lysolecithin needed per cell before any inhibition occurred. This was in fact observed; at concentrations less than 1 flg./106 cells, no inhibition occurred. (A similar minimum was observed for BP8 cells and lymphocytes: it was the slope of the inhibition curve that varied.) The stimulation of oxygen uptake observed in lymphocytes at low lysolecithin concentrations might be explained by entry of very small amounts into the cell, stabilizing the mitochondria according to the suggestion put forward by Saunders (1957) .
With respect to a possibly greater action of lysolecithin on tumour cells than on normal cells, two observations are important. Ponder and Ponder (1964) found that extracts of tumour cells had a greater haemolytic activity than extracts of lung or liver. They postulated the existence of lysolecithin inhibitor, which was more strongly bound in normal tissues. Furthermore, Gray (1963) found that although there was no great increase of lysolecithin in Landschutz and BP8 ascites tumours, the membrane lipids had a less specific organization of fatty acids and a rather high proportion of breakdown products. He suggested that " the presence of substantial amounts of monoglyceride, phosphatidic acid and lysolecithin may reflect a tendency to general breakdown of tumour lipids, perhaps by enzymes released by changes in membrane permeability ". Both explanations would account for an increased sensitivity to lysolecithin.
In conclusion, care must be taken in extrapolating these results to conditions in solid tumours in vivo. Unknown factors e.g. the amount of lysin-inhibitors such as albumin in the extracellular fluid, and the ability of lysolecithin micelles to diffuse through the extracellular space-must be taken into account. Furthermore, the effect of lysolecithin on tumour capillaries, and the possibilities of haemorrhage or increased vascular permeability (Cater and Taylor, 1966) may complicate the issue. The present results, however, have suggested that further work along such lines might be rewarding. SUMMARY 1. A method is described for measuring the oxygen uptake of cell suspensions in vitro, by means of Silver's oxygen cathode.
2. BP8 ascites and rat hepatoma cells had a higher respiratory rate on a per cell basis than polymorphonuclear leucocytes, lymphocytes, or macrophages.
3. Lysolecithin inhibited the oxygen uptake of all cell types studied, at concentrations greater than 1.0 /ag./106 cells. The degree of inhibition was proportional to the logarithm of the dose of lysolicithin per cell. In terms of surface area, tumour cells were more sensitive than lymphocytes or polymorphonuclear leucocytes. 4. Concentrations of lysolecithin less than 1 ,ug./106 cells caused no inhibition of oxygen uptake. In two experiments, such concentrations stimulated the oxygen uptake of lymphocytes.
5. Low concentrations of lysolecithin caused an increase in the apparent KmO2 value for the cells.
6. Lysolecithin-treated cells characteristically showed increased permeability to Trypan Blue, distortion of the cell membrane, and often coagulation.
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